STOCKHOLDERS EQUITY (DEFICIT)

12 Months Ended

Mar. 31, 2025

STOCKHOLDERS EQUITY (DEFICIT)

STOCKHOLDERS' EQUITY (DEFICIT)

NOTE 4 – STOCKHOLDERS’ EQUITY (DEFICIT)

Common Stock

The Company is authorized to issue 3,000,000,000 shares of common stock.

The Company has no potentially dilutive securities, such as options or warrants, currently issued and outstanding.

On November 16, 2021, the board of directors approved a 5-in-1 reverse stock split for the Company’s common stock while waiting for approval from the Financial Industry Regulatory Authority (“FINRA”) as of this Annual Report filing. The reverse stock split was retrospectively reflected throughout the consolidated financial statements and footnotes.

On February 14, 2023, the Company entered into Subscription Agreements for Placement of Shares with the six targeted subscribers. The Company raised proceeds of US$120,000 with par value of US$0.001 per share, and issue 120,000,000 shares to the targeted subscribers. These common shares became effective from February 22, 2023

As of March 31, 2025, and 2024, the Company has 121,983,993 shares of common stock issued and outstanding.